Know Labs Initiated at Speculative Buy by Benchmark

Know Labs Initiated at Speculative Buy by Benchmark

Dow JonesApr 8 08:14 ET

Know Labs Price Target Announced at $1.00/Share by Benchmark

Know Labs Price Target Announced at $1.00/Share by Benchmark

Dow JonesApr 8 08:14 ET

Express News | Benchmark Initiates Coverage On Know Labs With Speculative Buy Rating, Announces Price Target of $1

Moomoo 24/7Apr 8 08:03 ET

Know Labs Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/08/2024 56.01% Benchmark → $1 Initiates Coverage On → Speculative Buy

BenzingaApr 8 08:02 ET

Know Labs to Present Clinical Research at the 2024 American Physiology Summit

The Company demonstrates significant progress since presenting at last year's Summit. Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been

BusinesswireApr 5 09:00 ET

Know Labs Reports Promising Results From Clinical Study

TipRanksMar 6 16:25 ET